Mobile CRISPRi Plasmids for Stable Bacterial Integration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current CRISPRi systems face challenges in establishing effective and stable genomic integration across diverse bacteria, limiting their widespread use for dissecting bacterial gene function and studying microbiome interactions.

Innovation Solution

Development of CRISPRi systems and methods that enable modular, stable genomic integration and ease of transfer to diverse bacteria through conjugation, using artificial DNA constructs with sgRNAs, dCas9, antibiotic resistance genes, and nucleotide transfer sequences like Tn7L and Tn7R transposon sequences or ICE elements, facilitating genetic dissection and analysis of bacterial physiology and host-microbe interactions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If CRISPRi systems are established in bacteria, then gene expression blocking capability is achieved, but stable genomic integration and ease of transfer to diverse bacteria remain difficult

Engineering Contradiction:
Improvegene expression blocking capabilityVSAvoidtransferability to diverse bacteria
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent creates a universal CRISPRi system that functions across diverse bacterial species by using a standardized plasmid backbone (pJMP1337) with broad-host-range conjugation elements. The system maintains consistent sgRNA-dCas9 repression mechanism while adapting to different bacterial hosts through mobile genetic elements, enabling one system to serve multiple bacterial species.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent introduces mobile genetic elements (Tn7 transposon, ICE Bs1) as intermediaries that mediate the transfer of CRISPRi components between bacteria. These elements act as bridges, carrying the CRISPRi plasmid from donor to recipient cells through conjugation, thereby enabling cross-species transfer without requiring species-specific adaptation of the core repression mechanism.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If CRISPRi components are transferred between bacteria, then ease of transfer is improved, but stable genomic integration is compromised

Engineering Contradiction:
Improveease of transferVSAvoidgenomic integration stability
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The patent incorporates mobile genetic elements (Tn7 transposon, ICE Bs1) into the plasmid design beforehand, preparing the CRISPRi construct for efficient conjugative transfer. These pre-integrated elements enable the plasmid to self-transfer between bacteria without requiring additional manipulation, while the plasmid maintains its ability to stably maintain CRISPRi components during and after transfer.

Inventive Principle:
Principle #10Preliminary action

3Adaptability or versatility

If mobile genetic elements are used for transfer, then ease of transfer to diverse bacteria is improved, but plasmid size increases

Engineering Contradiction:
Improvetransfer to diverse bacteriaVSAvoidplasmid size
Core Design Contradiction:
Adaptability or versatilityVSVolume of stationary object

Solution Approach 1:

The patent segments the CRISPRi system into modular components: the core repression elements (sgRNA, dCas9), the mobile genetic elements (Tn7 transposon or ICE Bs1), and the plasmid backbone. This segmentation allows the mobile elements to be optimized for transfer efficiency while the core CRISPRi components remain compact, enabling the system to achieve broad transferability without excessive plasmid size increase.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS12018258B2Mobile-CRISPRi plasmids and related methods
Publication Date: 2024.06.25 CZ BIOHUB SF LLC
  • US12018258B2 patent drawing
  • US12018258B2 patent drawing
  • US12018258B2 patent drawing

AI summary

Described in this disclosure are CRISPRi systems and methods, along with the related compositions and kits, that combine modularity, stable genomic integration, and ease of transfer to diverse bacteria by conjugation. CRISPRi compositions, methods, systems and kits described herein allow for genetic dissection of bacteria, facilitating analyses of microbiome function, antibiotic resistances and sensitivities, as well as comprehensive screening for host-microbe interactions. Embodiments of the invention comprise compositions, methods, systems, and kits for CRISPRi-based repression of gene expression in bacteria.